A shared perspective
We need partnerships between pharma and patient groups to thrive more than ever, says OVID Health's Jenny Ousbey, as the firm launches the first ever Patient Partnerships Index with PharmaTimes
COVID-19 will rightfully continue to dominate the news and our thoughts over the course of the pandemic and beyond, but it is also important to highlight some of the great positives of pharma and healthcare that can risk going unnoticed, particularly during times of crisis.
As such, as well as keeping you up-to-date on coronavirus and other, unrelated industry developments in our daily news stream and PharmaTimes Magazine, we have exciting news to announce.
For one, we have significantly upgraded the digital edition of PharmaTimes Magazine (http://magazine.pharmatimes.com/) with new design features to further improve readability on mobile, tablet and desktop devices.
This issue sees the first ever annual Women in Healthcare feature, which kicks off on page 18 and is simply designed to highlight some of the brightest stars in pharma and healthcare and their successes.
Alongside partner OVID Health, PharmaTimes is also thrilled to launch the new Patient Partnership Index, which will celebrate the pharma companies that really stand out with regard to their communication and engagement with patient groups, thus providing a valuable platform for learning and spreading best practice in meaningful patient-centricity.
See Jenny Ousbey’s related article on the need for thriving partnerships between pharma and patient groups on page 14.
I hope you enjoy the issue!
We need partnerships between pharma and patient groups to thrive more than ever, says OVID Health's Jenny Ousbey, as the firm launches the first ever Patient Partnerships Index with PharmaTimes
Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it
How personalised medicine and population health can work together and the role that pharma can play
After ploughing untold investment into building comprehensive regulatory databases, life sciences organisations should turn their attention to unlocking the rich business insights they contain
Would you trust a pharma brand with your life?
Roshani Perera looks at the provision of psychological support services for men living with prostate cancer and their carers and families across England
PharmaTimes talks to Carreen McCay about her 10 year-old son Henry’s experiences with haemophilia A
Claire Bennett, Bionical Emas, Vice President of Data Management
Ellie Matthews, Bionical Emas, Head of Project Management, EAP
Dr Nuala Murphy, ICON plc, President Clinical Research Services
Shairose Ebrahim, integrated medhealth communication (imc), Founder, President and Chief Executive
Johanna Jarvis, Pi Healthcare, Managing Director
Elizabeth Rapley, Edge Medical Communications, Managing Director
Stephanie Hall, Uptake Strategies, Managing Director and Founder
Kim Innes, Teva UK, General Manager UK & Ireland
Harriet Lewis, Chiesi, Head of Public Affairs
Emma Rooth, Torbay Pharmaceuticals, Managing Director
Dima Samaha, Certara, Senior Director - Value Strategy & Payer Insights
Sarah Scanlon, Janssen, Business Unit Director: Oncology, Haematology, Cardiopulmonary and Digital
Caroline Kelly, Pharma Integrity, Managing Director
Victoria Blackbeard, Eradigm Consulting, Consultant
Dr Juliet Roberts, Boehringer Ingelheim, UK & Ireland Medical Director
Laura Coyle, Lundbeck, District Manager
Dr Dennise Broderick, Galen, President and Managing Director
Deborah Kobewka, Evaluate, Chief Executive
Claire Knapp, Havas Lynx Group, Managing Director
Sarah Price, Havas Lynx Group, Director of Media
Ebony Samuels, Parexel International, Vice President
Bianca Coulter, Coulter Partners, Chief Executive
Stuart Henderson considers the need to transform clinical trials during COVID-19